We are live on ! Find out more
HRTX icon

Heron Therapeutics
HRTX

152 hedge funds and large institutions have $2.24B invested in Heron Therapeutics in 2018 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 54 increasing their positions, 39 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

147% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 19

79% more capital invested

Capital invested by funds: $1.25B → $2.24B (+$991M)

60% more funds holding in top 10

Funds holding in top 10: 5 → 8 (+3)

38% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 39

23% more funds holding

Funds holding: 124 → 152 (+28)

18.42% more ownership

Funds ownership: 107.15% → 125.57% (+18%)

10% more call options, than puts

Call options by funds: $39.4M | Put options by funds: $35.7M

Holders
152
Holders Change
+28
Holders Change %
+22.58%
% of All Funds
3.48%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.18%
New
47
Increased
54
Reduced
39
Closed
19
Calls
$39.4M
Puts
$35.7M
Net Calls
+$3.62M
Net Calls Change
-$7.32M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$49.3M
2
BBA
Baker Bros. Advisors
New York
+$44.6M
3
EAM
Eagle Asset Management
Florida
+$41.1M
4
ACH
ArrowMark Colorado Holdings
Colorado
+$34.7M
5
BM
Bridger Management
New York
+$29M

Top Sellers

1
CC
Carlson Capital
Texas
-$26.2M
2
Franklin Resources
Franklin Resources
California
-$26.2M
3
RCMNY
Rubric Capital Management (New York)
New York
-$15.6M
4
Citadel Advisors
Citadel Advisors
Florida
-$15M
5
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$12.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
PPA
51
Parametric Portfolio Associates
Washington
$3.1M +$1.28M +56,643 +101%
Fisher Asset Management
52
Fisher Asset Management
Washington
$3.08M -$217K -9,568 -8%
CCM
53
Copernicus Capital Management
California
$2.98M +$2.45M +108,000 New
Allianz Asset Management
54
Allianz Asset Management
Germany
$2.98M -$37.8K -1,665 -2%
Mirae Asset Global Investments
55
Mirae Asset Global Investments
South Korea
$2.96M -$1.66M -73,200 -41%
Voloridge Investment Management
56
Voloridge Investment Management
Florida
$2.84M +$2.33M +102,854 New
Swiss National Bank
57
Swiss National Bank
Switzerland
$2.77M +$40.8K +1,800 +2%
PAM
58
Private Asset Management
California
$2.63M +$184K +8,125 +9%
Federated Hermes
59
Federated Hermes
Pennsylvania
$2.55M +$470K +20,708 +29%
CM
60
Crestline Management
Texas
$2.51M -$576K -25,374 -22%
AA
61
ALPS Advisors
Colorado
$2.38M +$583K +25,679 +43%
California State Teachers Retirement System (CalSTRS)
62
California State Teachers Retirement System (CalSTRS)
California
$2.28M +$251K +11,082 +15%
RA
63
Royce & Associates
New York
$2.28M – – –
ACM
64
Asymmetry Capital Management
California
$2.13M -$495K -21,835 -22%
EGI
65
EAM Global Investors
California
$1.87M +$1.54M +67,801 New
CIP
66
Chartwell Investment Partners
Pennsylvania
$1.85M -$3.06M -135,022 -67%
CS
67
Credit Suisse
Switzerland
$1.7M +$292K +12,869 +26%
Wells Fargo
68
Wells Fargo
California
$1.67M +$637K +28,095 +87%
California Public Employees Retirement System
69
California Public Employees Retirement System
California
$1.65M – – –
CM
70
Castleark Management
Illinois
$1.64M +$1.35M +59,575 New
GH
71
GAM Holding
Switzerland
$1.63M – – –
New York State Common Retirement Fund
72
New York State Common Retirement Fund
New York
$1.62M +$231K +10,200 +21%
AllianceBernstein
73
AllianceBernstein
Tennessee
$1.55M -$1.24M -54,600 -49%
State of Wisconsin Investment Board
74
State of Wisconsin Investment Board
Wisconsin
$1.52M +$499K +22,000 +67%
Ameriprise
75
Ameriprise
Minnesota
$1.41M +$1.16M +51,066 New
1 2
3
4 5

HRTX Hedge Fund Activity: Q1 2018 in Review

152 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Heron Therapeutics (HRTX) for Q1 2018, worth a combined $2.24B — up 79% from $1.25B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new HRTX positions and 19 closed out — a net gain of 28 holders — while 54 added to existing stakes and 39 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $49.3M. The largest seller was Carlson Capital, cutting an estimated $26.2M.

  • 152 institutional investors held Heron Therapeutics (HRTX) as of Q1 2018, up from 124 in Q4 2017.
  • Funds reported $2.24B of Heron Therapeutics stock for Q1 2018, up 79% quarter-over-quarter.
  • 47 funds opened new Heron Therapeutics positions in Q1 2018 and 19 closed out, a net change of +28 holders.
  • The largest Heron Therapeutics buyer in Q1 2018 was Wellington Management Group, an estimated $49.3M added.
  • The largest Heron Therapeutics seller in Q1 2018 was Carlson Capital, an estimated $26.2M sold.

Based on aggregated 13F filings for Q1 2018.